- |||||||||| Neupogen (filgrastim) / Kyowa Kirin, Amgen, plerixafor / Generic mfg.
Trial completion, Trial completion date: Collection of Transplant Stem Cells for Plasma Cell Myeloma (clinicaltrials.gov) - Mar 7, 2018 P2, N=49, Completed, Active, not recruiting --> Completed | Trial completion date: Mar 2017 --> Mar 2018 Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jan 2018
- |||||||||| Phase classification, Trial primary completion date: Clinical Performance of the Embrace Isothermal Mattress (clinicaltrials.gov) - Oct 9, 2017
P=N/A, N=36, Completed, Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jan 2018 Phase classification: P1 --> P=N/A | Trial primary completion date: Sep 2012 --> Dec 2012
- |||||||||| NN1213 / Novo Nordisk
Trial completion, Phase classification: Study of Antioxidants and Oxidants in Malnourished Children (clinicaltrials.gov) - Aug 1, 2017 P=N/A, N=86, Completed, Phase classification: P1 --> P=N/A | Trial primary completion date: Sep 2012 --> Dec 2012 Recruiting --> Completed | Phase classification: P1 --> PN/A
- |||||||||| Neupogen (filgrastim) / Kyowa Kirin, Amgen, plerixafor / Generic mfg.
Trial primary completion date: Collection of Transplant Stem Cells for Plasma Cell Myeloma (clinicaltrials.gov) - Apr 14, 2017 P2, N=49, Active, not recruiting, Recruiting --> Completed | Phase classification: P1 --> PN/A Trial primary completion date: Apr 2017 --> Jun 2014
- |||||||||| Enrollment closed, Enrollment change, Trial primary completion date: Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES) (clinicaltrials.gov) - Feb 11, 2017
P=N/A, N=544, Active, not recruiting, Trial primary completion date: Apr 2017 --> Jun 2014 Recruiting --> Active, not recruiting | N=700 --> 544 | Trial primary completion date: Jul 2016 --> Feb 2017
- |||||||||| Neupogen (filgrastim) / Kyowa Kirin, Amgen, plerixafor / Generic mfg.
Enrollment closed, Enrollment change: Collection of Transplant Stem Cells for Plasma Cell Myeloma (clinicaltrials.gov) - Sep 15, 2016 P2, N=49, Active, not recruiting, Recruiting --> Active, not recruiting | N=700 --> 544 | Trial primary completion date: Jul 2016 --> Feb 2017 Recruiting --> Active, not recruiting | N=70 --> 49
- |||||||||| Trial completion: Post-Approval Clinical Trial of the PCM (clinicaltrials.gov) - May 21, 2015
P3, N=494, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Trial completion: PCM Cervical Disc System (clinicaltrials.gov) - Mar 5, 2015
P3, N=494, Completed, Recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Neupogen (filgrastim) / Kyowa Kirin, Amgen, plerixafor / Generic mfg.
Trial primary completion date: Collection of Transplant Stem Cells for Plasma Cell Myeloma (clinicaltrials.gov) - Oct 20, 2014 P2, N=70, Recruiting, Trial primary completion date: Sep 2014 --> Dec 2014 Trial primary completion date: Feb 2015 --> Apr 2017
- |||||||||| amoxicillin / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Pilot Study of PUFA-optimized RUTF for Severe Acute Malnutrition (clinicaltrials.gov) - Sep 29, 2014 P=N/A, N=141, Completed, Trial primary completion date: Feb 2015 --> Apr 2017 Recruiting --> Completed | N=100 --> 141 | Trial primary completion date: Apr 2014 --> Jul 2014
- |||||||||| Trial completion date: PCM Cervical Disc System (clinicaltrials.gov) - Apr 20, 2014
P3, N=494, Active, not recruiting, Recruiting --> Completed | N=100 --> 141 | Trial primary completion date: Apr 2014 --> Jul 2014 Trial completion date: Apr 2014 --> Aug 2014
- |||||||||| Trial initiation date: Post-Approval Clinical Trial of the PCM (clinicaltrials.gov) - Oct 28, 2013
P3, N=494, Active, not recruiting, Not yet recruiting --> Completed Initiation date: Jan 2005 --> Apr 2013
- |||||||||| Enrollment closed: Post-Approval Clinical Trial of the PCM (clinicaltrials.gov) - Jul 17, 2013
P3, N=494, Active, not recruiting, Initiation date: Jan 2005 --> Apr 2013 Not yet recruiting --> Active, not recruiting
|